About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

About Us: Management

 
 

7/7/2010 - Daxor Announces that Rush University Medical Center of Chicago, IL Acquires BVA-100 Blood Volume Analyzer

  

5/27/2010 - Daxor Announces Publication of Review Article on Use of Blood Volume Analysis to Guide Ultrafiltration in the Management of Congestive Heart Failure

  

5/10/2010 - Daxor Corporation Announces First Quarter 2010 Earnings and Payment of a Dividend

  
 

______________________

 
     
  DAXOR Corporation Newsletter; Issue 1, March 2010  
  2009 Form 10-K  
  2009 Second Quarter Earnings  
  September 2009 10-Q  
  2009 Proxy Statement  
  2008 Annual Report  
 

 

 
Executive Team

Joseph Feldschuh, M.D.

President and CEO

Stephen Feldschuh

Chief Operating Officer

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Deanna O'Brien

Vice President, Quality Systems and Regulatory Affairs

Everis Engstrom

Vice President, Engineering

Gary Fischman, Ph.D.

Vice President, Research and Development
   
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company

Stanley Epstein, M.D.

Director of the Company

Mario Biaggi, Jr.

Director of the Company
   
Medical Advisory Board  

Philip Frost, M.D.

 

Robert L. Rosenthal, M.D.

 

Fred Gilbert, M.D.

 

James H. Brassel, M.D.

 
Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2010 DAXOR Corporation. All Rights Reserved.